Skip to main content
Erschienen in: Clinical Rheumatology 3/2021

13.08.2020 | Original Article

Interleukin 6, interleukin 17, disease-related and contextual factor association with depression, and its severity in patients with rheumatoid arthritis

verfasst von: Eman Salah Albeltagy, Shaimaa Younes Abd Elaziz, Sarah Younes Abozaid, Hala Mohamed El Zomor, Sally Said Abd Elhamed

Erschienen in: Clinical Rheumatology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Depression is very prevalent in rheumatoid arthritis (RA) compared with the general population and may be associated with poor clinical outcomes. Identifying factors associated with depression could improve outcomes for this at risk group. However, few studies have comprehensively examined the association of contextual and disease-related factors as well as pro inflammatory cytokines interleukin 6 (IL-6) and interleukin 17 (IL-17) with depression in RA. Therefore, we aimed to identify the factors significantly associated with depression and severe depression in RA, thus providing a reference for applying clinical care interventions for patients with RA.

Methods

An observational cross-sectional study was conducted on 120 RA patients. Potential determinants included contextual and disease-related factors and laboratory variables. Enzyme-linked immunosorbent assay was used to measure serum IL-6 and IL-17 levels. Depression was assessed using the Arabic version of the Beck Depression Inventory-II questionnaire.

Results

A total of 120 patients were included, and up to 67.5% had some degree of depression with 60% having moderate to severe depression. The severity of disease activity of RA (DAS28-ESR (OR, 1.63; 95% CI, 0.899-3.755), HAQ scores (OR, 1.27; 95% CI, 0.702-2.933), and VAS scores for pain (OR, 2.2; 95% CI, 1.251–5.223)), besides elevated serum IL-6 (OR, 1.51; 95% CI, 0.832-3.475), IL-17 (OR, 1.28; 95% CI, 0.706-2.947), and CRP levels (OR, 1.20; 95% CI, 0.923-2.882) were significantly associated with depression and its severity in the multivariate analysis.

Conclusion

Depression is frequent in RA and is strongly associated to elevated serum IL-6, IL-17, CRP levels, and disease activity-related factors.
Key Points
• RA patients are at increased risk of developing depression, particularly if their level of disease activity scores, serum IL-6, and IL-17 levels increases.
• Patient characteristics associated with depression in RA include living without family, without employments, and with co-morbid hypertension, while RA disease factors are pain, functional disability, and high disease activity.
• A multidisciplinary cooperative approach to RA patient care with regular assessments of these factors associated with depression should be incorporated into routine care programs to improve patients’ self care capabilities and mitigate or prevent depression in these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36:182–188CrossRef Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36:182–188CrossRef
2.
3.
Zurück zum Zitat Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:2136–2148CrossRef Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:2136–2148CrossRef
4.
Zurück zum Zitat Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG et al (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the Hospital Anxiety and Depression Scale (HADS). BMC Psychiatry 12:6CrossRef Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG et al (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the Hospital Anxiety and Depression Scale (HADS). BMC Psychiatry 12:6CrossRef
5.
Zurück zum Zitat Sturgeon JA, Finan PH, Zautra AJ (2016) Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol 12(9):532–542CrossRef Sturgeon JA, Finan PH, Zautra AJ (2016) Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol 12(9):532–542CrossRef
8.
Zurück zum Zitat Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752CrossRef Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752CrossRef
9.
Zurück zum Zitat Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019PubMed Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019PubMed
10.
Zurück zum Zitat Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H et al (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75(6):965–973CrossRef Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H et al (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75(6):965–973CrossRef
11.
Zurück zum Zitat Wang Y-P, Gorenstein C (2013) Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression InventoryII. Clinics 68(9):1274–1287CrossRef Wang Y-P, Gorenstein C (2013) Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression InventoryII. Clinics 68(9):1274–1287CrossRef
13.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588CrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588CrossRef
14.
Zurück zum Zitat Prevoo ML, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRef Prevoo ML, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRef
15.
Zurück zum Zitat Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The clinical value of the stanford health assessment questionnaire functional disability index in patients with rheumatoid arthritis. J Rheumatol 15(10):1480–1488PubMed Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The clinical value of the stanford health assessment questionnaire functional disability index in patients with rheumatoid arthritis. J Rheumatol 15(10):1480–1488PubMed
16.
Zurück zum Zitat Bruce B, Fries JF (2003) The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol 30(1):167–178PubMed Bruce B, Fries JF (2003) The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol 30(1):167–178PubMed
17.
Zurück zum Zitat Beck AT, Steer RA, Brown GK, San Antonio TX (1996) Psychological Corporation; 1996. Manual for the Beck Depression Inventory–II Beck AT, Steer RA, Brown GK, San Antonio TX (1996) Psychological Corporation; 1996. Manual for the Beck Depression Inventory–II
18.
Zurück zum Zitat Ghareeb A, Cairo G (2000) Egypt: Angle Press. Manual of the Arabic BDI-II Ghareeb A, Cairo G (2000) Egypt: Angle Press. Manual of the Arabic BDI-II
19.
Zurück zum Zitat Alansari BM (2005) Kuwait: The New Book Home Co., Kuwait University. Beck Depression Inventory (BDI-II) Sourcebook of Personality disorders Scales Alansari BM (2005) Kuwait: The New Book Home Co., Kuwait University. Beck Depression Inventory (BDI-II) Sourcebook of Personality disorders Scales
21.
Zurück zum Zitat Rezaei F, Doost HT, Molavi H, Abedi MR, Karimifar M (2014) Depression and pain in patients with rheumatoid arthritis: mediating role of illness perception. Egypt Rheumatol 36(2):57–64CrossRef Rezaei F, Doost HT, Molavi H, Abedi MR, Karimifar M (2014) Depression and pain in patients with rheumatoid arthritis: mediating role of illness perception. Egypt Rheumatol 36(2):57–64CrossRef
22.
Zurück zum Zitat Mostafa H, Radwan A (2013) The relationship between disease activity and depression in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 35(4):193–199CrossRef Mostafa H, Radwan A (2013) The relationship between disease activity and depression in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 35(4):193–199CrossRef
24.
Zurück zum Zitat Hassan AA, Nasr MH, Mohamed AL, Kamal AM, Elmoghazy AD (2019) Psychological affection in rheumatoid arthritis patients in relation to disease activity. Medicine (Baltimore) 98(19):e15373CrossRef Hassan AA, Nasr MH, Mohamed AL, Kamal AM, Elmoghazy AD (2019) Psychological affection in rheumatoid arthritis patients in relation to disease activity. Medicine (Baltimore) 98(19):e15373CrossRef
26.
Zurück zum Zitat Tekaya R, Saadi F, Mahmoud I, Saidane O, Abdelmoula LC, Chaabouni L, Zouari R (2012) Assessment of depression in rheumatoid arthritis: a cross sectional study on 60 patients. Presse Med 415:e220–e225CrossRef Tekaya R, Saadi F, Mahmoud I, Saidane O, Abdelmoula LC, Chaabouni L, Zouari R (2012) Assessment of depression in rheumatoid arthritis: a cross sectional study on 60 patients. Presse Med 415:e220–e225CrossRef
29.
Zurück zum Zitat Guerrero-López JB, Cabrera DM, Lara-Mu MDC, García RO (2017) Evaluation of quality of life and depression in patients with rheumatoid arthritis in a General Hospital. Rev Colomb Reumatol 24:199–204 Guerrero-López JB, Cabrera DM, Lara-Mu MDC, García RO (2017) Evaluation of quality of life and depression in patients with rheumatoid arthritis in a General Hospital. Rev Colomb Reumatol 24:199–204
30.
Zurück zum Zitat Kwiatkowska B, Kłak A, Maślińska M, Mańczak M, Raciborski F (2018) Factors of depression among patients with rheumatoid arthritis. Reumatologia 56(4):219–227CrossRef Kwiatkowska B, Kłak A, Maślińska M, Mańczak M, Raciborski F (2018) Factors of depression among patients with rheumatoid arthritis. Reumatologia 56(4):219–227CrossRef
32.
Zurück zum Zitat Yousefi F, Mansor MB, Juhari RB (2010) The relationship between gender, age, depression and academic achievement. Curr Res Psychol 6:61–66 Yousefi F, Mansor MB, Juhari RB (2010) The relationship between gender, age, depression and academic achievement. Curr Res Psychol 6:61–66
33.
Zurück zum Zitat Dickens C, McGowan L, Clark D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with meta- analysis. Psychosom Med 64:52–60CrossRef Dickens C, McGowan L, Clark D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with meta- analysis. Psychosom Med 64:52–60CrossRef
34.
Zurück zum Zitat Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C et al (2017) Depression in rheumatoid arthritis. Rev Colomb Reumatol 24:84–91 Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C et al (2017) Depression in rheumatoid arthritis. Rev Colomb Reumatol 24:84–91
35.
Zurück zum Zitat Zabsonré WJ, Kaboré F, Nanema D, Savadogo B, Dravé A, Sompougdou C, Ouedraogo M, Ouédraogo D (2019) Frequency and factors associated with depression in rheumatoid arthritis in African Black Patients: case-control study. Open J Rheumatol Autoimmun Dis 09:35–41CrossRef Zabsonré WJ, Kaboré F, Nanema D, Savadogo B, Dravé A, Sompougdou C, Ouedraogo M, Ouédraogo D (2019) Frequency and factors associated with depression in rheumatoid arthritis in African Black Patients: case-control study. Open J Rheumatol Autoimmun Dis 09:35–41CrossRef
38.
Zurück zum Zitat Matcham F, Davies R, Hotopf M, Hyrich K, Norton S, Steer S (2018) Galloway J (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kex528 Matcham F, Davies R, Hotopf M, Hyrich K, Norton S, Steer S (2018) Galloway J (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). https://​doi.​org/​10.​1093/​rheumatology/​kex528
39.
Zurück zum Zitat Bechman K, Sin FE, Ibrahim F et al (2018) Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial. RMD Open 4:e000676CrossRef Bechman K, Sin FE, Ibrahim F et al (2018) Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial. RMD Open 4:e000676CrossRef
43.
Zurück zum Zitat Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowsk C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD (2009) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010 85:S3–S14. https://doi.org/10.4065/mcp.2009.0649CrossRef Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowsk C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD (2009) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010 85:S3–S14. https://​doi.​org/​10.​4065/​mcp.​2009.​0649CrossRef
44.
Zurück zum Zitat Krishnadas R, Krishnadas R, Cavanagh J (2011) Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature. J Med Case Rep 5(1):1–5CrossRef Krishnadas R, Krishnadas R, Cavanagh J (2011) Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature. J Med Case Rep 5(1):1–5CrossRef
45.
Zurück zum Zitat Wada K, Yamada N, Sati T et al (2001) Corticosteroid-induced psychotic and mood disorders:diagnosis definef by DSM-IV and clinical picture. Psychosomatics 42:461–466CrossRef Wada K, Yamada N, Sati T et al (2001) Corticosteroid-induced psychotic and mood disorders:diagnosis definef by DSM-IV and clinical picture. Psychosomatics 42:461–466CrossRef
Metadaten
Titel
Interleukin 6, interleukin 17, disease-related and contextual factor association with depression, and its severity in patients with rheumatoid arthritis
verfasst von
Eman Salah Albeltagy
Shaimaa Younes Abd Elaziz
Sarah Younes Abozaid
Hala Mohamed El Zomor
Sally Said Abd Elhamed
Publikationsdatum
13.08.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 3/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05326-7

Weitere Artikel der Ausgabe 3/2021

Clinical Rheumatology 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.